Hemogenyx Pharmaceuticals Plc HOPHF

Set alert

Price alert · HOPHF

All alert types
2.33 USD 0.00 0.00%

At close · Oct 29

0.04 Day range 0.04
2.33 52-week range 2.33
YTD
0.00%
1 year
0.00%
Open
0.04
Prev close
2.33
Mkt cap
16.07M
Vol
25.00K
Avg vol
0
EPS
-3.14
P/E
0.00
More statistics
Low
0.04
High
0.04

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for HOPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-11.69 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -0.8×
FY 2016: -32.4×FY 2017: -10.6×FY 2018: -23.7×FY 2019: -24.4×FY 2020: -21.8×FY 2021: -3.3×FY 2022: -2.9×FY 2023: -5.3×FY 2024: -0.5×FY 2025: -0.8×
FY 2016 5y median -2.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 6.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 3.6×FY 2025: 6.4×
FY 2016 5y median 0.0× FY 2025
P/FCF -2.2×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.8×FY 2025: -2.2×
FY 2016 5y median -0.0× FY 2025
EV/EBITDA -0.9×
FY 2016: 1.6×FY 2017: 2.2×FY 2018: 0.3×FY 2019: -0.5×FY 2020: 0.1×FY 2021: 2.6×FY 2022: -0.2×FY 2023: 2.7×FY 2024: -1.2×FY 2025: -0.9×
FY 2016 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -44.9%
FY 2016: -3062.2%FY 2017: -2067.4%FY 2018: -3754.4%FY 2019: -3430.0%FY 2020: -4329.1%FY 2021: -20572.7%FY 2022: -29246.7%FY 2023: -17527.7%FY 2024: -127.0%FY 2025: -44.9%
FY 2016 5y median -17527.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -816.5%
FY 2016: -111.8%FY 2017: -110.8%FY 2018: -161.0%FY 2019: 418.6%FY 2020: -233.7%FY 2021: -62.2%FY 2022: -121.5%FY 2023: -0.2%FY 2024: -626.1%FY 2025: -816.5%
FY 2016 5y median -121.5% FY 2025
ROIC -194.4%
FY 2016: -66.6%FY 2017: -40.0%FY 2018: -76.7%FY 2019: -181.1%FY 2020: -85.9%FY 2021: -33.1%FY 2022: 60.0%FY 2023: -0.1%FY 2024: -137.9%FY 2025: -194.4%
FY 2016 5y median -33.1% FY 2025
ROA -233.7%
FY 2016: -96.5%FY 2017: -98.6%FY 2018: -67.2%FY 2019: -138.2%FY 2020: -78.1%FY 2021: -59.8%FY 2022: -56.1%FY 2023: -0.1%FY 2024: -133.4%FY 2025: -233.7%
FY 2016 5y median -59.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -29.8%
FY 2016: -170.2%FY 2017: -89.7%FY 2018: -93.2%FY 2019: -0.1%FY 2020: -27.7%FY 2021: -25.7%FY 2022: 247.9%FY 2023: -100.2%FY 2024: -83072.3%FY 2025: -29.8%
FY 2016 FY 2025
EPS (diluted) -3.3%
FY 2016: -8990.9%FY 2017: -179.2%FY 2018: 52.6%FY 2019: 6.4%FY 2020: -24.8%FY 2021: -31.3%FY 2022: 38.6%FY 2023: -46.3%FY 2024: 10.1%FY 2025: -3.3%
FY 2016 FY 2025
Free Cash Flow 16.9%
FY 2016: -685.8%FY 2017: -10.8%FY 2018: -166.3%FY 2019: 12.0%FY 2020: -62.7%FY 2021: -74.8%FY 2022: 3.1%FY 2023: -86.3%FY 2024: 33.3%FY 2025: 16.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 4.5×FY 2017: 7.4×FY 2018: 11.1×FY 2019: 3.1×FY 2020: 1.1×FY 2021: 20.2×FY 2022: 3.5×FY 2023: 3.3×FY 2024: 0.7×FY 2025: 1.4×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 1.4×
FY 2016: 10.4×FY 2017: 7.4×FY 2018: 11.1×FY 2019: 3.1×FY 2020: 1.1×FY 2021: 20.2×FY 2022: 3.5×FY 2023: 3.3×FY 2024: 0.7×FY 2025: 1.4×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 1.7×
FY 2016: 0.3×FY 2017: 0.0×FY 2018: 1.2×FY 2019: -3.6×FY 2020: 1.8×FY 2021: 0.0×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 2.9×FY 2025: 1.7×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 1.7×FY 2017: 2.2×FY 2018: 0.4×FY 2019: -0.5×FY 2020: 0.1×FY 2021: 2.7×FY 2022: -0.2×FY 2023: 2.7×FY 2024: -0.5×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -30.4×
FY 2016: -38.8×FY 2017: -81.1×FY 2018: -945×FY 2019: -53.8×FY 2020: -64.7×FY 2021: -1.0×FY 2022: 121138×FY 2023: -28.0×FY 2024: -15.8×FY 2025: -30.4×
FY 2016 5y median -15.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31